Rhodolirium andicola: a new renewable source of alkaloids with acetylcholinesterase inhibitory activity, a study from nature to molecular docking

Abstract

Acetylcholinesterase is an important target for control of neurodegenerative diseases causing cholinergic signaling deficit. Traditionally, galanthamine has been used as an Amaryllidaceae-derived acetylcholinesterase inhibitor, although new Amaryllidaceae plants could serve as source for better acetylcholinesterase inhibitors. Therefore, the objective of this study was to characterize the alkaloid composition from bulbs of Rhodolirium andicola (Poepp.) Traub, a native Chilean Amaryllidaceae specie, and assess their inhibitory activity on acetylcholinesterase by in vitro and in silico methodologies. Alkaloidal extracts from R. andicola exhibited an inhibitory activity with IC50 values between 11.25 ±0.04 and 57.78 ± 1.92 μg/ml that included isolated alkaloid, galanthamine (2.3 ± 0.18 μg/ml), Additionally, 12 alkaloids were detected using gas chromatography-mass spectrometry and identified by comparing their mass fragmentation patterns with literature and database NIST vs.2.0. To better understand the bioactivity of isolated compounds and alkaloidal extracts against acetylcholinesterase, a molecular docking approach was performed. Results suggested that alkaloids such as lycoramine, norpluvine diacetate and 6α-deoxy-tazettine expand the list of potential acetylcholinesterase inhibitors to not only galanthamine. The role of R. andicola as a source for acetylcholinesterase inhibitors is further discussed in this study.

References

  1. Atanasova, M., Yordanov, N., Dimitrov, I., Berkov, S., Doytchinova, I., 2005. Molecular docking study on galantamine derivatives as cholinesterase inhibitors. Mol. Inform. 34, 394–403.

    Article  Google Scholar 

  2. Barnard, E.A., 1974. Neuromusculartransmission- enzymatic destruction of acetylcholine. In: Hubbard, J.I. (Ed.), The Peripheral Nervous System. Plenum Press, New York, pp. 201–224.

    Google Scholar 

  3. Bartolucci, C., Perola, E., Pilger, C., Fels, G., Lamba, D., 2001. Three-dimensional structure of a complex of galanthamine (Nivalin) with acetylcholinesterase from Torpedo californica: implications for the design of new anti-Alzheimer drugs. Proteins 42, 182–191.

    CAS  Article  PubMed Central  Google Scholar 

  4. Berkov, S., Codina, C., Viladomat, F., Bastida, J., 2008. N-alkylated galanthamine derivatives: potent acetylcholinesterase inhibitors from Leucojum aestivum. Bioorg. Med. Chem. Lett. 18, 2263–2266.

    CAS  Article  PubMed Central  Google Scholar 

  5. Berkov, S., Evstatieva, L., Popov, S., 2004. Alkaloids in Bulgarian Pancratium mariti-mum L. Z. Naturforsch. 59c, 65–69.

    Article  Google Scholar 

  6. Berkov, S., Viladomat, F., Codina, C., Suárez, S., Ravelo, A., Bastida, J., 2012. GC-MS of amaryllidaceous galanthamine-type alkaloids. J. Mass. Spectrom. 47, 1065–1073.

    CAS  Article  PubMed Central  Google Scholar 

  7. Bulger, P.G., Bagal, S.K., Marquez, R., 2008. Recent advances in biomimetic natural product synthesis. Nat. Prod. Rep. 25, 254–297.

    CAS  Article  PubMed Central  Google Scholar 

  8. Cortes, N., Alvarez, R., Osorio, E.H., Alzate, F., Berkov, S., Osorio, E., 2015. Alkaloids metabolite profiles by GC-MS and acetylcholinesterase inhibitory activities with bending-mode predictions of five Amaryllidaceae plants. J. Pharm. Biomed. Anal. 102, 222–228.

    CAS  Article  PubMed Central  Google Scholar 

  9. de Andrade, J.P., Guo, Y., Font-Bardia, M., Calvet, T., Dutilh, J., Villadomat, F., Codina, C., Nair, J.J., Zuanazzi, J.A.S., Bastidas, J., 2014. Crinine-type alkaloids from Hippeastrum alicum and H. calyptratum. Phytochemistry 103, 188–195.

    Article  PubMed Central  Google Scholar 

  10. de Andrade, J.P., Giordani, R.P., Torras-Claviera, L., Pigni, N.B., Berkov, S., Font-Bardia, M., Calvet, T., Konrath, E., Bueno, K., Sachett, L.G., Dutil, J.H., de Sousa Borgues, W., Villadomat, F., Henriques, A.T., Nair, J.J., Zuanazzi, J.A.S., Bastidas, J., 2016. The Brazilian Amaryllidaceae as source of acetylcholinesterase inhibitory alkaloids. Phytochem. Rev. 15, 147–160.

    Article  Google Scholar 

  11. Edgar, R.C., 2004. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 32, 1792–1797.

    CAS  Article  PubMed Central  Google Scholar 

  12. Elisha, I.L., Elgorashi, E.E., Hussein, A.A., Duncan, G., Eloff, J.N., 2013. Acetylcholinesterase inhibitory effects of the bulb of Ammocharis coranica (Amaryllidaceae) and its active constituent lycorine. S. Afr. J. Bot. 85, 44–47.

    CAS  Article  Google Scholar 

  13. Ellman, G.L., Courtney, D.K., Valentino Jr., A., Featherstone, R.M., 1961. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7, 88–95.

    CAS  Google Scholar 

  14. Gotti, R., Fiori, J., Bartolini, M., Cavrini, V., 2006. Analysis of Amaryllidaceae alkaloids from Narcissus by GC-MS and capillary electrophoresis. J. Pharm. Biomed. Anal. 42, 17–24.

    CAS  Article  PubMed Central  Google Scholar 

  15. Greenblatt, H.M., Kryger, G., Lewis, T., Silman, I., Sussman, J.L., 1999. Structure of acetylcholinesterase complexedwith(-)-galanthamineat 2.3 A resolution. FEBS Lett. 463, 321–326.

    CAS  Article  PubMed Central  Google Scholar 

  16. Greig, N.H., Utsuki, T., Yu, Q., Zhul, X., Holloway, H.W., Perry, T., Lee1, B., Ingram, D.K., Lahir, D.K., 2001. A new therapeutic target in Alzheimer’s disease treatment: attention to butyrylcholinesterase. Curr. Med. Res. Opin. 17, 159–165.

    CAS  Article  PubMed Central  Google Scholar 

  17. Heinrich, M., Teoh, H.L., 2004. Galanthamine from snowdrop - the development of a modern drug against Alzheimer’s disease from local Caucasian knowledge. J. Ethnopharmacol. 92, 147–162.

    CAS  Article  PubMed Central  Google Scholar 

  18. Houghton, P.J., Rena, Y., Howes, M.J., 2006. Acetylcholinesterase inhibitors from plants and fungi. Nat. Prod. Rep. 23, 181–199.

    CAS  Article  PubMed Central  Google Scholar 

  19. Lee, S.S., Venkatesham, U., Rao, C.P., Lam, S.H., Lin, H.M., 2007. Preparation of sec-olycorines against acetylcholinesterase. Bioorg. Med. Chem. 15, 1034–1043.

    CAS  Article  PubMed Central  Google Scholar 

  20. López, S., Bastida, J., Viladomat, F., Codina, C., 2002. Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts. Life Sci. 71, 2521–2529.

    Article  PubMed Central  Google Scholar 

  21. Marco, L., Carreiras, M.D., 2006. Galanthamine, a natural product for the treatment of Alzheimer’s disease. Recent Pat. CNS Drug. Discov. 1, 105–111.

    CAS  Article  PubMed Central  Google Scholar 

  22. Mehndiratta, M.M., Pandey, S., Kuntzer, T., 2011. Acetylcholinesterase inhibitor treatment for myasthenia gravis. Cochrane Database Syst. Rev. 2, 1–20.

    Google Scholar 

  23. Mehta, M., Adem, A., Sabbagh, M., 2012. New acetylcholinesterase inhibitors for Alzheimer’s disease. Int. J. Alzheimers Dis., https://doi.org/10.1155/2012/728983.

    Google Scholar 

  24. Morris, G.M., Goodsell, S.D., Halliday, R.S., Huey, R.S., Hart, R., Belew, R.K., Olson, J., 1998. Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J. Comput. Chem. 19, 1639–1662.

    CAS  Article  Google Scholar 

  25. Mukherjee, P.K., Kumar, V., Mal, M., Houghton, P.J., 2007. Acetylcholinesterase inhibitors from plants. Phytomedicine 14, 289–300.

    CAS  Article  PubMed Central  Google Scholar 

  26. Ortiz, J.E., Berkov, S., Pigni, N.B., Theoduloz, C., Roitman, G., Tapia, A., Bastida, J., Feresin, G., 2012. Wild Argentinian Amaryllidaceae, a new renewable source of the acetylcholinesterase inhibitor galanthamine and other alkaloids. Molecules 17, 13473–13482.

    CAS  Article  PubMed Central  Google Scholar 

  27. Ortiz, J.E., Pigni, N.B., Andujar, S.A., Roitman, G., Suvire, F.D., Enriz, R.D., Tapia, A., Bastida, J., Feresin, G.E., 2016. Alkaloids from Hippeastrum argentinum and their cholinesterase-inhibitory activities: an in vitro and in silico study. J. Nat. Prod. 79, 1241–1248.

    CAS  Article  PubMed Central  Google Scholar 

  28. Perry, E.K., 1986. The cholinergic hypothesis, ten years on. Br. Med. Bull. 42, 63–69.

    CAS  Article  PubMed Central  Google Scholar 

  29. Rahman, A.U., Choudhary, M.I., 2001. Bioactive natural products as a potential source of new pharmacophores a theory of memory. Pure Appl. Chem. 73, 555–560.

    Article  Google Scholar 

  30. Ravena, P., 2003. Elucidation and systematics of the Chilean genera of Amaryllidaceae. Bot. Aust. 2, 1–21.

    Google Scholar 

  31. Rhee, I.K., Appels, N., Hofte, B., Karabatak, B., Erkelens, C., Stark, L.M., Flippin, L.A., Ver-poorte, R., 2004. Isolation of the acetylcholinesterase inhibitor ungeremine from Nerine bowdenii by preparative HPLC coupled on-line to a flow assay system. Biol. Pharm. Bull. 27, 1804–1809.

    CAS  Article  PubMed Central  Google Scholar 

  32. Rhee, I.K., Van Rijn, R.M., Verpoorte, R., 2003. Qualitative determination of false-positive effects in the acetylcholinesterase assays using thin layer chromatography. Phytochem. Anal. 14, 127–131.

    CAS  Article  PubMed Central  Google Scholar 

  33. Schulz, V., 2003. Ginkgo extract or cholinesterase inhibitors in patients with dementia: what clinical trial and guidelines fail to consider. Phytomedicine 10, 74–79.

    CAS  Article  PubMed Central  Google Scholar 

  34. Sheng-Dian, H., Yul, Z., Hong-Ping, H., Shi-Fei, L., Gui-Hua, T., Duo-Zhi, Ch., Ming-Ming, C., Ying-Tong, D., Xiao-Jiang, H., 2013. A new Amarylliceae alkalolid from the bulbs ofLycoris radiate. Chin. J. Nat. Med. 11, 406–410.

    Google Scholar 

  35. Stryer, L., 1995. Biochemistry, 4th ed. W.H. Freeman & Co., New York.

    Google Scholar 

  36. Tram, N., Mitova, M., Bankova, V., Handjieva, N., Popov, S.S., 2014. GC-MS ofCrinum latifolium L. alkaloids. Z. Naturforsch. C 57, 239–242.

    Article  Google Scholar 

  37. Wang, Y.H., Wan, Q.L., Gu, Ch.D., Luo, H.R., Long Ch., L., 2012. Synthesis and biological evaluation of lycorine derivatives as dual inhibitors of human acetylcholinesterase and butyrylcholinesterase. Chem. Cent. J., https://doi.org/10.1186/1752-153X-6-96.

    Google Scholar 

  38. Waterhouse, A.M., Procter, J.B., Martin, D.M.A., Clamp, M., Barton, G.J., 2009. Jalview Version 2 - a multiple sequence alignment editor and analysis work bench. Bioin-formatics 25, 1189–1191.

    CAS  Article  Google Scholar 

  39. World Alzheimer Report, 2015. The Global Impact of Dementia, http://www.worldalzreport2015.org/(accessed 11.08.17).

    Google Scholar 

  40. Zarotsky, V., Sramek, J.J., Cutler, N.R., 2003. Galanthamine hydrobromide: an agent for Alzheimer’s disease. Am. J. Health-Syst. Pharmacist. 60, 446–452.

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Emilio Hormazábal.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Moraga-Nicolás, F., Jara, C., Godoy, R. et al. Rhodolirium andicola: a new renewable source of alkaloids with acetylcholinesterase inhibitory activity, a study from nature to molecular docking. Rev. Bras. Farmacogn. 28, 34–43 (2018). https://doi.org/10.1016/j.bjp.2017.11.009

Download citation

Keywords

  • Amaryllidaceae
  • Alkaloids
  • Acetylcholinesterase inhibitors
  • Molecular docking